|
|
||||||||||||||||||||||||
HIV Assessment News |
|
|||||||||||||||||||||||
Neuropsychological Assessment |
||||||||||||||||||||||||
"Although global cognitive functioning among participants was in the Average range, children with minimal to moderate CT brain scan abnormalities scored significantly lower than children with normal scans on composite measures of cognitive functioning and five specific subtests, especially tasks involving executive functions. Furthermore, children with worse immune status (CD4+ counts < 500) scored lower on subtests measuring processing speed. Viral load was unrelated to cognitive test scores" (pp. 633-634). In summarizing these findings, Martin and colleagues suggest that, "whereas many HIV-infected children being treated with HAART are functioning within normal limits, a subset of children with CNS [central nervous system] disease continues to follow a distinct pattern of low average to below average cognitive functioning. The cognitive deficits in these children may be a result of ongoing viral replication in the CNS despite virologic control in the periphery ..., or residual effects of static HIV-related CNS disease" (p. 649). The investigators conclude that "children with HIV being treated with HAART remain at risk for developing CNS disease. Findings emphasize the importance of conducting neuropsychological [NP] assessments in this population, particularly for children with cortical atrophy and absolute CD4+ cell counts < 500" (p. 634).
|
|
|||||||||||||||||||||||
|
| |